跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLMESARTAN HCT - MYL 20/12.5 olmesartan medoxomil 20 mg and hydrochlorothiazide 12.5mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
OLMESARTAN HCT - MYL 20/12.5 olmesartan medoxomil 20 mg and hydrochlorothiazide 12.5mg tablet blister pack
Approved
STANDARD
OLMESARTAN HCT - MYL 20/12.5 olmesartan medoxomil 20 mg and hydrochlorothiazide 12.5mg tablet blister pack
ORGANON PHARMA PTY LTD
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
27fc94e827da57c1
Company
ORGANON PHARMA PTY LTD
Type
Standard
Approval Details
Approval Id
27fc94e827da57c1
Product Name
OLMESARTAN HCT - MYL 20/12.5 olmesartan medoxomil 20 mg and hydrochlorothiazide 12.5mg tablet blister pack
Artg Id
273576
Artg Name
OLMESARTAN HCT - MYL 20/12.5 olmesartan medoxomil 20 mg and hydrochlorothiazide 12.5mg tablet blister pack
Sponsor
ORGANON PHARMA PTY LTD
Company Detail Path
/organization/organon-pharma-pty-ltd
Artg Date
2016-06-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-02052-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-02051-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
27fc94e827da57c1
Type
Standard
Back to TGA Approvals